周五,生命科学工具公司Avantor(纽交所代码:AVTR)股价盘中大跌6.2%,引发了市场广泛关注。股价大跌的原因或与公司上季度业绩不佳有关。
公司当日发布的第四季度财报显示,Avantor报告期内净销售额为16.9亿美元,同比下降2%,低于市场预期的17.1亿美元。外汇兑换及业务剥离的影响导致有机销售增长仅为1%。此外,公司调整后每股收益为0.27美元,较去年同期的0.29美元有所下滑,尽管超出0.26美元的市场预期。
不过,公司对2025年前景保持乐观,预计有机销售增长1%-3%,调整后息税折旧及摊销前利润率为18%-19%。公司同时预计调整后每股收益为1.02美元至1.10美元,自由现金流为6.5亿美元至7亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.